# Monopar Therapeutics: Form DEF 14A, filed Apr 30, 2025

- Company: [Monopar Therapeutics](/companies/mnpr.md) (CIK 1645469)
- Form: DEF 14A
- Filed: 2025-04-30
- Accepted by EDGAR: Apr 30, 2025, 15:34 ET
- Period: 2025-06-17
- Accession: 0001437749-25-013824
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm

Filed Apr 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-013824. Last ingested by Listed: Nov 4, 2026, 20:49 ET. No prices; not investment advice.